Evidence map›Paper›PMID 40283964›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Uvarinol and Dichamanetin Derived from

Emmanuel Ayodeji Agbebi, Shalom Oluwafunke Adeyemi, Adetola Ibukunoluwa Adewale, Omolara Seun Ajofoyinbo, Ezekiel Abiola Olugbogi, Oluwatoyin Mary Oyinloye, Iyadunni Adesola Anuoluwa, Timothy Oluwaseyi Agbebi, Basiru Olaitan Ajiboye, Babatunji Emmanuel Oyinloye

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Emmanuel Ayodeji AgbebiInstitute for Drug Research and Development, S.E. Bogoro Center, Afe Babalola University, Ado-Ekiti 360001, Nigeria.ORCID 0000-0001-9258-3095
Shalom Oluwafunke AdeyemiInstitute for Drug Research and Development, S.E. Bogoro Center, Afe Babalola University, Ado-Ekiti 360001, Nigeria.ORCID 0000-0002-7011-8202
Adetola Ibukunoluwa AdewaleInstitute for Drug Research and Development, S.E. Bogoro Center, Afe Babalola University, Ado-Ekiti 360001, Nigeria.ORCID 0000-0002-8177-0044
Omolara Seun AjofoyinboDepartment of Science and Laboratory Technology, Ekiti State University, Ado-Ekiti 362103, Nigeria.
Ezekiel Abiola OlugbogiDepartment of Biochemistry, School of Basic Medical Sciences, Babcock University, Ilishan-Remo 121003, Nigeria.ORCID 0000-0003-1415-8856
Oluwatoyin Mary OyinloyeDepartment of Biological Sciences, College of Sciences, Afe Babalola University, Ado-Ekiti 360001, Nigeria.
Iyadunni Adesola AnuoluwaDepartment of Microbiology, Faculty of Science, University of Medical Sciences, Ondo 351101, Nigeria.
Timothy Oluwaseyi AgbebiDepartment of Physiology, College of Medicine, University of Ibadan, Ibadan 200005, Nigeria.
Basiru Olaitan AjiboyePhytomedicine and Molecular Toxicology Research Laboratory, Department of Biochemistry, Federal University Oye-Ekiti, Oye-Ekiti 371104, Nigeria.
Babatunji Emmanuel OyinloyeInstitute for Drug Research and Development, S.E. Bogoro Center, Afe Babalola University, Ado-Ekiti 360001, Nigeria.ORCID 0000-0003-2165-7936

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

DichamanetinMethicillin-resistant Staphylococcus aureus (MRSA)penicillin-binding protein 2a (PBP2a)Uvaria chamaeUvarinol

Identifiers

PMID40283964
PMCPMC12030409

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.